BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
84 results:

  • 1. HDAC8-mediated inhibition of ep300 drives a transcriptional state that increases melanoma brain metastasis.
    Emmons MF; Bennett RL; Riva A; Gupta K; Carvalho LADC; Zhang C; Macaulay R; Dupéré-Richér D; Fang B; Seto E; Koomen JM; Li J; Chen YA; Forsyth PA; Licht JD; Smalley KSM
    Nat Commun; 2023 Nov; 14(1):7759. PubMed ID: 38030596
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions.
    Tian Y; Ma J; Wang H; Yi X; Wang H; Zhang H; Guo S; Yang Y; Zhang B; Du J; Shi Q; Gao T; Guo W; Li C
    Cell Mol Life Sci; 2023 Oct; 80(11):315. PubMed ID: 37801083
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Acetylation reprograms MITF target selectivity and residence time.
    Louphrasitthiphol P; Loffreda A; Pogenberg V; Picaud S; Schepsky A; Friedrichsen H; Zeng Z; Lashgari A; Thomas B; Patton EE; Wilmanns M; Filippakopoulos P; Lambert JP; Steingrímsson E; Mazza D; Goding CR
    Nat Commun; 2023 Sep; 14(1):6051. PubMed ID: 37770430
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The C-terminal transactivation domain of MITF interacts promiscuously with co-activator CBP/p300.
    Brown AD; Lynch K; Langelaan DN
    Sci Rep; 2023 Sep; 13(1):16094. PubMed ID: 37752231
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Characterization of molecular mechanisms driving Merkel cell polyomavirus oncogene transcription and tumorigenic potential.
    Yang JF; Liu W; You J
    PLoS Pathog; 2023 Aug; 19(8):e1011598. PubMed ID: 37647312
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor.
    Brown AD; Vergunst KL; Branch M; Blair CM; Dupré DJ; Baillie GS; Langelaan DN
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119520. PubMed ID: 37353163
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dermatological findings in Rubinstein-Taybi Syndrome.
    Cammarata-Scalisi F; Diociaiuti A; Cárdenas Tadich A; Sandoval X; Oranges T; Filippeschi C; Araya Castillo M; Willoughby CE; Cerri A; Gervasini C; Callea M
    Ital J Dermatol Venerol; 2023 Aug; 158(4):316-320. PubMed ID: 37282850
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan.
    Ogata D; Nishio S; Hatta N; Kaji T; Fujii K; Mikami M; Kiyohara Y; Enomoto T
    Melanoma Res; 2023 Aug; 33(4):300-308. PubMed ID: 37162526
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
    Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
    Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations.
    Solomon DA; Ramani B; Eiger-Moscovich M; Milman T; Uludag G; Crawford JB; Phan I; Char DH; Shields CL; Eagle RC; Bastian BC; Bloomer MM; Pekmezci M
    Ophthalmology; 2022 Dec; 129(12):1429-1439. PubMed ID: 35835335
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
    Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
    Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis.
    Shin Y; Kim S; Ghate NB; Rhie SK; An W
    Oncogene; 2022 Jan; 41(4):560-570. PubMed ID: 34785776
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation.
    Dacus D; Wallace NA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452526
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors.
    Zhang F; Tang X; Fan S; Liu X; Sun J; Ju C; Liang Y; Liu R; Zhou R; Yu B; Zhang C; Zhang Z; Kang T; Huang G; Lv XB
    Oncogene; 2021 Jun; 40(24):4137-4150. PubMed ID: 34017080
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of genetic mutations related to invasion and metastasis of acral melanoma via whole-exome sequencing.
    Lim Y; Lee DY
    J Dermatol; 2021 Jul; 48(7):999-1006. PubMed ID: 33890690
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
    Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
    Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis.
    Chai P; Yu J; Jia R; Wen X; Ding T; Zhang X; Ni H; Jia R; Ge S; Zhang H; Fan X
    Nucleic Acids Res; 2020 Dec; 48(21):12135-12150. PubMed ID: 33196849
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
    Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
    Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution.
    Louphrasitthiphol P; Siddaway R; Loffreda A; Pogenberg V; Friedrichsen H; Schepsky A; Zeng Z; Lu M; Strub T; Freter R; Lisle R; Suer E; Thomas B; Schuster-Böckler B; Filippakopoulos P; Middleton M; Lu X; Patton EE; Davidson I; Lambert JP; Wilmanns M; Steingrímsson E; Mazza D; Goding CR
    Mol Cell; 2020 Aug; 79(3):472-487.e10. PubMed ID: 32531202
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.